Skip to main content
Beta Drugs Limited logo

Beta Drugs Limited — Investor Relations & Filings

Ticker · BETA ISIN · INE351Y01019 LEI · 984500A89888DB9E6T57 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 431 across all filing types
Latest filing 2023-11-03 Call Transcript
Country IN India
Listing National Stock Exchange of India BETA

About Beta Drugs Limited

https://www.betadrugslimited.com

Beta Drugs Limited specializes in the development, manufacture, and marketing of oncology formulations. The company provides a comprehensive portfolio of anti-cancer drugs across various therapeutic segments, including cytotoxic injectables, lyophilized products, tablets, and capsules. Its manufacturing capabilities encompass a wide range of oncology treatments such as chemotherapy agents and supportive care medications. The organization operates advanced production facilities designed to meet international quality standards, focusing on high-potency active pharmaceutical ingredients and finished dosage forms. The company serves diverse markets through its own branded products and contract manufacturing services, aiming to provide affordable and high-quality cancer care solutions. Its core competency lies in its specialized focus on the oncology niche and its integrated approach to pharmaceutical production.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is an invitation and announcement for an upcoming earnings conference call to discuss the operational and financial performance for the half-year period H1 FY24. It includes details about the date, time, speakers, and dial-in numbers for the call. There is no actual financial data or results presented in the document, only an announcement of the call. According to the filing definitions, a full text transcript of the conference call (including Q&A) would be classified as a Call Transcript (CT), but this document is only the invitation and announcement for the call, not the transcript itself. Therefore, the correct classification is Call Transcript (CT) as it relates to the conference call content, but since this is only the invitation, the best fit is still CT because it is directly related to the earnings call event. Confidence is high due to clear mention of earnings conference call and no financial data present.
2023-11-03 English
Board Meeting — Financial Results/Other business matters
Board/Management Information Classification · 95% confidence The document is a formal notice addressed to the National Stock Exchange of India regarding a forthcoming Board Meeting scheduled for November 7, 2023. The notice states the agenda includes consideration and approval of unaudited financial results for the half year ended September 30, 2023, and migration of equity shares to the main board. The document is short (1418 characters) and serves as an intimation or announcement of a board meeting rather than containing any financial data or detailed report. It complies with SEBI regulations for disclosure. Therefore, this is a Board/Management Information filing, as it announces a board meeting and related corporate actions.
2023-10-30 English
Board Meeting — BETA DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for the p…
Regulatory Filings
2023-10-30 English
Board Meeting — Financial Results/Other business matters
Board/Management Information Classification · 95% confidence The document is a notification to the stock exchange about a forthcoming Board Meeting scheduled for November 7, 2023. It mentions the agenda items including approval of unaudited financial results for the half year ended September 30, 2023, and migration of equity shares to the main board. The document is an announcement of a meeting, not the financial results themselves or any detailed report. It is a compliance filing under SEBI regulations informing about the board meeting date and agenda. Given the content and length (1418 characters), this fits the category of Board/Management Information (MANG) as it relates to board meeting notification and agenda disclosure.
2023-10-30 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate issued under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. It confirms the processing of securities dematerialisation requests for the quarter ended 30th September 2023. The document is short (1688 characters) and serves as a compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or any report publication. It is not a report itself but a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2023-10-09 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled as the minutes of the 18th Annual General Meeting (AGM) of Beta Drugs Limited held on September 30, 2023. It details attendance, proceedings, resolutions passed including adoption of financial statements for the year ended March 31, 2023, appointment and re-appointment of directors, ratification of auditor remuneration, and alteration of the Memorandum of Association. It also describes the voting process including e-voting and poll, and mentions the appointment of a scrutinizer. The content is typical of AGM minutes, which are presentations and materials shared during the Annual General Meeting. There is no indication that this is the full Annual Report or any other type of filing. The document length (10,462 characters) and detailed content support classification as AGM Information rather than a brief announcement or regulatory filing.
2023-10-04 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.